Skip to main content
California Medicine logoLink to California Medicine
. 1950 Apr;72(4):234–238.

TREATMENT OF MIGRAINE—Results with Dihydroergocornine Methanesulfonate (DHO-180) and Other Ergot Derivatives

Nicholas A Bercel
PMCID: PMC1520523  PMID: 18731688

Abstract

A comparison of nicotinic acid, a non-narcotic analgesic and a series of injectable and oral ergot preparations tested by various methods in treating 40 patients with typical migraine indicate that ergot alkaloids are far superior in producing symptomatic relief.

A comparison of ergotamine tartrate, dihydroergotamine (DHE-45) and dihydroergocornine (DHO-180) indicated that ergotamine tartrate is the most effective and perhaps the most toxic, DHE-45 is slightly less effective and considerably less toxic, and that DHO-180 is the least effective but also the least toxic. When given orally, these alkaloids were about half as effective as when given by injection. EC-110 (ergotamine nitrate with caffeine) was the most effective.

DHO-180 in liquid form, given daily for one month, had a marked preventive effect on migraine attacks.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Wolff H. G., Hardy J. D., Goodell H. MEASUREMENT OF THE EFFECT ON THE PAIN THRESHOLD OF ACETYLSALICYLIC ACID, ACETANILID, ACETOPHENETIDIN, AMINOPYRINE, ETHYL ALCOHOL, TRICHLORETHYLENE, A BARBITURATE, QUININE, ERGOTAMINE TARTRATE AND CAFFEINE: AN ANALYSIS OF THEIR RELATION TO THE PAIN EXPERIENCE. J Clin Invest. 1941 Jan;20(1):63–80. doi: 10.1172/JCI101196. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES